Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited
HONG KONG, Jan. 11, 2025 /PRNewswire/ -- Dunxin Financial Holdings ("DXF" or the "Company") (OTC Pink: DXFFY, DXFFD) is pleased to announce that effective on January 10, 2025, the Company will change its name to "Eason Technology Limited" and its...
Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution
IRVINE, Calif., Jan. 11, 2025 /PRNewswire/ -- Corn Next, a leader in sustainable innovation and biodegradable solutions, has officially launched CornNext-17, a game-changing bio-based material designed to combat the global plastic pollution crisis....
Boqii Announces ADS Ratio Change
SHANGHAI, Jan. 11, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) today announced that it will change its ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS...
UGREEN Unveils Groundbreaking AI NAS with Built-In LLM at CES 2025
LAS VEGAS, Jan. 11, 2025 /PRNewswire/ -- UGREEN, a leading innovator in consumer electronics, made waves at CES 2025 with the unveiling of pioneering AI NAS solutions and other cutting-edge products. Under the launch event theme of "Activate the...
Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no plateau No treatment-related severe adverse events (AEs), with only 4% discontinuation rate due...
MicroCloud Hologram Inc. Researches Holographic Technology Based on Quantum Tensor Network States
SHENZHEN, China, Jan. 11, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), today announced the research on holographic technology based on quantum tensor network states. Quantum tensor network states are a...
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, similar to the preclinical stage KAT6 inhibitor (MEN2312) licensed a year ago and which advanced rapidly into...
Khadas Unveils Modular Mini PC Powered by Intel Core Ultra Series 2 at CES 2025
LAS VEGAS, Jan. 11, 2025 /PRNewswire/ -- At CES 2025, Khadas captivated global audiences with groundbreaking product designs and innovative technologies, showcasing the immense potential of next-generation computing devices. As a technology brand...